Sovenyr Subscribe

Signal2026-06-19

PubMed

Recent advances in glycoconjugate-based therapeutics.

Open primary source Read on Substack

Powered by Sovenyr — cross-source signal intelligence. Figures are collected data as-dated, not investment advice.